182 related articles for article (PubMed ID: 17049756)
21. In vivo evaluation of (+)-MR200 as a new selective sigma ligand modulating MOP, DOP and KOP supraspinal analgesia.
Marrazzo A; Parenti C; Scavo V; Ronsisvalle S; Scoto GM; Ronsisvalle G
Life Sci; 2006 Apr; 78(21):2449-53. PubMed ID: 16324720
[TBL] [Abstract][Full Text] [Related]
22. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
[TBL] [Abstract][Full Text] [Related]
23. Delta-1 opioid receptor-mediated antinociceptive properties of a nonpeptidic delta opioid receptor agonist, (-)TAN-67, in the mouse spinal cord.
Tseng LF; Narita M; Mizoguchi H; Kawai K; Mizusuna A; Kamei J; Suzuki T; Nagase H
J Pharmacol Exp Ther; 1997 Feb; 280(2):600-5. PubMed ID: 9023269
[TBL] [Abstract][Full Text] [Related]
24. Heterodimerization and cross-desensitization between the mu-opioid receptor and the chemokine CCR5 receptor.
Chen C; Li J; Bot G; Szabo I; Rogers TJ; Liu-Chen LY
Eur J Pharmacol; 2004 Jan; 483(2-3):175-86. PubMed ID: 14729105
[TBL] [Abstract][Full Text] [Related]
25. Opioid agonist and antagonist antinociceptive properties of [D-Ala2,Leu5,Cys6]enkephalin: selective actions at the deltanoncomplexed site.
Qi JA; Bowen WD; Mosberg HI; Rothman RB; Porreca F
J Pharmacol Exp Ther; 1990 Nov; 255(2):636-41. PubMed ID: 2173752
[TBL] [Abstract][Full Text] [Related]
26. Evidence for delta opioid receptor subtypes in rat spinal cord: studies with intrathecal naltriben, cyclic[D-Pen2, D-Pen5] enkephalin and [D-Ala2, Glu4]deltorphin.
Stewart PE; Hammond DL
J Pharmacol Exp Ther; 1993 Aug; 266(2):820-8. PubMed ID: 8394918
[TBL] [Abstract][Full Text] [Related]
27. Mu and delta opioid receptor desensitization in undifferentiated human neuroblastoma SHSY5Y cells.
Prather PL; Tsai AW; Law PY
J Pharmacol Exp Ther; 1994 Jul; 270(1):177-84. PubMed ID: 8035314
[TBL] [Abstract][Full Text] [Related]
28. Selective antagonism by naltrindole of the antinociceptive effects of the delta opioid agonist cyclic[D-penicillamine2-D-penicillamine5]enkephalin in the rat.
Drower EJ; Stapelfeld A; Rafferty MF; de Costa BR; Rice KC; Hammond DL
J Pharmacol Exp Ther; 1991 Nov; 259(2):725-31. PubMed ID: 1658309
[TBL] [Abstract][Full Text] [Related]
29. The role of spinal opioid receptors in antinociceptive effects produced by intrathecal administration of hydromorphone and buprenorphine in the rat.
Tejwani GA; Rattan AK
Anesth Analg; 2002 Jun; 94(6):1542-6, table of contents. PubMed ID: 12032023
[TBL] [Abstract][Full Text] [Related]
30. Spinal opioid receptors and adenosine release: neurochemical and behavioral characterization of opioid subtypes.
Cahill CM; White TD; Sawynok J
J Pharmacol Exp Ther; 1995 Oct; 275(1):84-93. PubMed ID: 7562600
[TBL] [Abstract][Full Text] [Related]
31. Cornea-responsive medullary dorsal horn neurons: modulation by local opioids and projections to thalamus and brain stem.
Hirata H; Takeshita S; Hu JW; Bereiter DA
J Neurophysiol; 2000 Aug; 84(2):1050-61. PubMed ID: 10938327
[TBL] [Abstract][Full Text] [Related]
32. Adaptations in nucleus accumbens circuitry during opioid withdrawal associated with persistence of noxious stimulus-induced antinociception in the rat.
Schmidt BL; Tambeli CH; Levine JD; Gear RW
J Pain; 2003 Apr; 4(3):141-7. PubMed ID: 14622711
[TBL] [Abstract][Full Text] [Related]
33. Opioid receptor subtypes differentially modulate serotonin efflux in the rat central nervous system.
Tao R; Auerbach SB
J Pharmacol Exp Ther; 2002 Nov; 303(2):549-56. PubMed ID: 12388635
[TBL] [Abstract][Full Text] [Related]
34. Activation of micro, delta or kappa opioid receptors by DAMGO, DPDPE, U-50488 or U-69593 respectively causes antinociception in the formalin test in the naked mole-rat (Heterocephalus glaber).
Towett PK; Kanui TI; Maloiy GM; Juma F; Olongida Ole Miaron J
Pharmacol Biochem Behav; 2009 Feb; 91(4):566-72. PubMed ID: 18929596
[TBL] [Abstract][Full Text] [Related]
35. Antinociception and delta-1 opioid receptors in the rat spinal cord: studies with intrathecal 7-benzylidenenaltrexone.
Hammond DL; Stewart PE; Littell L
J Pharmacol Exp Ther; 1995 Sep; 274(3):1317-24. PubMed ID: 7562504
[TBL] [Abstract][Full Text] [Related]
36. Interactions between chemokine and mu-opioid receptors: anatomical findings and electrophysiological studies in the rat periaqueductal grey.
Heinisch S; Palma J; Kirby LG
Brain Behav Immun; 2011 Feb; 25(2):360-72. PubMed ID: 20974247
[TBL] [Abstract][Full Text] [Related]
37. The stimulatory effect of mu- and delta-opioid receptors on bovine pinealocyte melatonin synthesis.
Chuchuen U; Ebadi M; Govitrapong P
J Pineal Res; 2004 Nov; 37(4):223-9. PubMed ID: 15485547
[TBL] [Abstract][Full Text] [Related]
38. Microinjection of opiates into the periaqueductal gray matter attenuates neuropathic pain symptoms in rats.
Sohn JH; Lee BH; Park SH; Ryu JW; Kim BO; Park YG
Neuroreport; 2000 May; 11(7):1413-6. PubMed ID: 10841348
[TBL] [Abstract][Full Text] [Related]
39. Comparison of the antinociceptive effect of acute morphine in female and male Sprague-Dawley rats using the long-lasting mu-antagonist methocinnamox.
Peckham EM; Barkley LM; Divin MF; Cicero TJ; Traynor JR
Brain Res; 2005 Oct; 1058(1-2):137-47. PubMed ID: 16139823
[TBL] [Abstract][Full Text] [Related]
40. Chemokine Receptor Antagonists in Combination with Morphine as a Novel Strategy for Opioid Dose Reduction in Pain Management.
Eisenstein TK; Chen X; Inan S; Meissler JJ; Tallarida CS; Geller EB; Rawls SM; Cowan A; Adler MW
Mil Med; 2020 Jan; 185(Suppl 1):130-135. PubMed ID: 32074321
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
